NORTHWEST BIOTHERAPEUTICS INC - COM (NWBO)

CUSIP: 66737P600

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / COM
Total 13F shares
3,214,516
Share change
+409,550
Total reported value
$2,009,124
Price per share
$0.62
Number of holders
13
Value change
+$254,851
Number of buys
2
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 66737P600?
CUSIP 66737P600 identifies NWBO - NORTHWEST BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NORTHWEST BIOTHERAPEUTICS INC - COM (NWBO) as of Q1 2023

As of 31 Mar 2023, NORTHWEST BIOTHERAPEUTICS INC - COM (NWBO) was held by 13 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,214,516 shares. The largest 10 holders included Sentinus, LLC, Ancora Advisors, LLC, Moloney Securities Asset Management, LLC, Opus Capital Group, LLC, Williams Jones Wealth Management, LLC., Ethos Financial Group, LLC, LEE DANNER & BASS INC, MAI Capital Management, GRACE & WHITE INC /NY, and AlphaMark Advisors, LLC. This page lists 13 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.